Clinical Trials Browser

INDUSTRY × Interventional × vorolanib × Clear all

NCT03792958 2022-11-14

Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT03095040 2021-02-08

CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

Phase 3 Unknown

Renal Cell Cancer Metastatic

NCT03848611 2020-07-09

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03904719 2020-07-09

CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

Phase 1 Completed

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT01863485 2019-07-05

Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

Phase 1 Completed

Advanced Cancer

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Phase 1 Unknown

Gastrointestinal

Advanced Gastric Cancer